The BBRC researcher and group leader gave a presentation on sources of variability in quantitative amyloid PET metrics
A study led by the Hospital del Mar Medical Research Institute, the Barcelonaβeta Brain Research Centre and the University of Gothenburg has compared the validity of nine biomarkers for the day-to-day diagnosis of Alzheimer's disease in hospital centres.
The research, within the European project EPAD, is headed by the Barcelonaβeta Brain Research Center (BBRC), a research center of the Pasqual Maragall Foundation, together with the University of Bristol.
The award is a recognition of the trajectory of the researcher, recipient in addition to a Knowledge Generation Project 2021
In the research, led by the BBRC, 250 people without cognitive alterations from the ALFA Study, promoted by the ”la Caixa” Foundation, have participated.
The consortium has officially ended its formal operation after six years of joint efforts and collaboration.
As indicated by Biogen y Eisai, the results show a 27% slowing of cognitive impairment in patients in the early stages of Alzheimer's disease.
In the research, led by the Barcelonaβeta Brain Research Center (BBRC), a research center of the Pasqual Maragall Foundation, 314 people without cognitive alterations from the Alfa Study, which has the support of the ”la Caixa” Foundation, have participated - DESTACAT
Thanks to the Alfa study, which has the support of the ”la Caixa” Foundation, much progress has been made in recent years in the identification of the early pathophysiological characteristics of Alzheimer's disease, as well as in the its early detection and in the development of prevention strategies.